A Chinese medicine-based herbal formula developed in Taiwan called Taiwan Chingguan Erhau (清冠二號), or NRICM102, could reduce the mortality rate of COVID-19 cases who experience severe symptoms by 50 percent, National Research Institute of Chinese Medicine (NRICM) director Su Yi-chang (蘇奕彰) said.
Su talked about the treatment on Sunday at the Taipei Traditional Chinese Medicine International Forum, saying that following the success of Taiwan Chingguan Yihau (清冠一號), or NRICM101, the institute is applying for patents and trademarks for the new formulation.
In 2020, permission was granted to export Taiwan Chingguan Yihau, and it has been sold in more than 50 countries with positive responses from overseas, Su said.
Photo: Tsai Si-pei, Taipei Times
Taiwan Chingguan Yihau received emergency use authorization in May last year from the Ministry of Health and Welfare, which allowed it to be manufactured and used for clinical treatment in Taiwan.
Eight pharmaceutical companies have authorization to manufacture the formula.
Taiwan Chingguan Erhau is a modification of its predecessor, which includes indigowoad root, heartleaf houttuynia herb and scutellaria root, among others, Su said.
Ingredients “helpful in fighting viruses” and “regulating the immune system” remain in Taiwan Chingguan Erhau, while stronger substances that “help bolster health maintenance” were substituted for those with modest effects, he added.
Clinical trials of Taiwan Chingguan Yihau were conducted from May to August last year in 15 hospitals including the Tri-Service General Hospital, Taipei Hospital and Taoyuan General Hospital.
Results showed that the chance of people with COVID-19 developing severe symptoms was reduced by 80 percent if they were using the formula, Su said.
Over the same period, more than 100 cases with severe symptoms received Taiwan Chingguan Erhau in clinical trials, with results suggesting a 50 percent drop in mortality rate within 30 days, he said.
Asking pharmaceutical companies to target only COVID-19 cases with severe symptoms is impractical as the pandemic wanes, Su said, adding that the institute plans to test Taiwan Chingguan Erhau’s usefulness against other severe lung diseases.
The formula’s effectiveness in treating chronic obstructive pulmonary disease, cardiac and pulmonary arrest, and pulmonary embolism are being assessed, he said.
Su also said that unlike Western medicines that target one disease, a Chinese medical formula can usually treat many diseases.
Taking Chinese medicine is unlikely to produce side effects or develop resistance the same way drugs or antibiotics do, he said.
Su said that the institute plans to approach companies that are interested in manufacturing Taiwan Chingguan Erhau and follow the procedures for launching new medical treatments in Taiwan.
SEND A MESSAGE: Sinking the amphibious assault ship, the lead warship of its class, is meant to show China the US Navy is capable of sinking their ships, an analyst said The US and allied navies plan to sink a 40,000-tonne ship at the latest Rim of the Pacific (RIMPAC) exercise to simulate defeating a Chinese amphibious assault on Taiwan. This year’s RIMPAC — the 29th iteration of the world’s largest naval exercise — involves the US, 28 partners, more than 25,000 personnel, 40 warships, three submarines and more than 150 aircraft operating in and around Hawaii from yesterday to Aug. 1, the US Navy said in a press release. The major components of the event include multidomain warfare exercises in multiship surface engagements, anti-submarine warfare and multi-axis defense of a carrier strike
Taiwanese could risk being extradited to China when traveling in countries with close ties to Beijing, Taiwan Association of University Professors deputy chairman Chen Li-fu (陳俐甫) said on Friday. Chen’s comments came after China on Friday last week announced new judicial guidelines targeting Taiwanese independence advocates. Myanmar, Cambodia, Laos and Djibouti are among the countries where Taiwanese could risk being extradited to China, he said. The Mainland Affairs Council (MAC) on Thursday elevated the travel alert for China, Hong Kong and Macau to “orange” after Beijing announced its guidelines to “severely punish Taiwanese independence diehards for splitting the country and inciting secession.” Extradition treaties
The airspace around Taiwan Taoyuan International Airport and Taipei International Airport (Songshan airport) is to be closed for an hour on July 25 and July 23 respectively, due to the Han Kuang military exercises, the Ministry of National Defense said yesterday. The annual exercise is to be held on Taiwan proper and its outlying islands from July 22 to 26. During last year’s exercise, the military conducted anti-aircraft landing drills at the Taoyuan airport for the first time, for which a one-hour no-fly ban was issued. Based on a live-fire bulletin sent out by the Maritime and Port Bureau, the nation’s
Taiwan and Thailand have signed an agreement to promote and protect bilateral investment and trade, the Executive Yuan’s Office of Trade Negotiations (OTN) said on Friday. The agreement on “Promotion and Protection of Investments” was signed by Representative to Thailand Chang Chun-fu (張俊福) and Thailand Trade and Economic Office in Taipei executive director Narong Boonsatheanwong on Thursday, the OTN said in a news release. Thailand has become the fifth trading partner to sign an investment agreement with Taiwan since 2016, following earlier agreements with the Philippines, India, Vietnam and Canada, the OTN said. The deal marks a significant milestone in the development of